Why the study?
Does intravenous L-arginine infusion improve renal plasma flow compared to D-arginine in healthy young men?
Does intravenous L-arginine infusion improve renal plasma flow compared to D-arginine in healthy young men?
L-arginine infusion at 100 mg/kg for 30 minutes is a suitable tool to assess endothelium-dependent vasodilation of the human renal vasculature without causing systemic hemodynamic changes.
Answers are grounded in this paper and cite their sources.
L-arginine infusion at 100 mg/kg validates a probe for renal endothelial function in healthy men; extends its utility for targeted vascular studies without systemic effects.
Systemic administration of L-arginine alters renal haemodynamics in humans. We examined whether L-arginine-induced vasodilation of the renal vasculature is related to an increased production and release of NO by comparing the effects of L- and D-arginine on renal endothelium-dependent vasodilation. In a double-blind randomized cross-over study including 20 young, healthy male white subjects (age 26±2 years), we determined the effects of intravenous administration of L-arginine or its enantiomer D-arginine, at doses of 100 mg/kg body weight for 30 min or 500 mg/kg for 30 min, on renal haemodynamics. Renal plasma flow (RPF) and glomerular filtration rate (GFR) were assessed by a constant-infusion input-clearance technique (using p-aminohippuric acid and inulin respectively). In addition, changes in blood pressure, heart rate, urinary sodium excretion (UNa) and urinary cGMP were measured. HPLC was used to determine L- and D-arginine concentrations. Intravenous infusion of L-arginine at 100 mg/kg for 30 min increased RPF from 641±87 to 677±98 ml/min (P = 0.019), whereas infusion of D-arginine did not (from 642±74 to 657±86 ml/min; not significant). The change in RPF was more marked during the infusion of L-arginine than during the infusion of D-arginine (+36±61 versus +16±57 ml/min; P = 0.037). Infusion of both L- and D-arginine at doses of 500 mg/kg for 30 min increased RPF from baseline [from 641±87 to 762±133 ml/min (P < 0.001) and from 642±74 to 713±120 ml/min (P = 0.004) respectively], but the change in RPF again was greater in response to L-arginine infusion than to infusion with D-arginine (+121±97 versus +71±94 ml/min; P = 0.018). In accordance, changes in renal vascular resistance (RVR) were higher in response to L-arginine compared with D-arginine for both doses (P < 0.05 and P< 0.001 respectively). UNa increased only with L-arginine (change in UNa, +0.33±0.26 mmol/min; P< 0.01) but not with D-arginine (change in UNa, +0.11±0.17 mmol/min; not significant). The change in UNa was more pronounced during infusion of L-arginine compared with infusion of D-arginine (P = 0.023). In parallel, urinary excretion of cGMP only increased in response to L-arginine (+676±272 pmol/l; P = 0.038) and not during D-arginine infusion (+185±153 pmol/l; not significant). L-Arginine-induced changes in RPF, RVR, UNa and cGMP excretion differed significantly from those induced by D-arginine. Thus although no direct measurements of NO synthesis were performed, putative markers of NO synthesis suggest that the renal vasodilatory response to L-arginine, at least in part, was due to increased production and release of NO. The dose of L-arginine at 100 mg/kg for 30 min emerged as the most suitable, because of the absence of systemic haemodynamic changes. The effects of infusion of L-arginine at 500 mg/kg for 30 min on renal endothelium-dependent vasodilation need to be corrected for the effects of D-arginine before conclusions can be drawn.
No takes yet. Share an insight, caveat, or question.
SCHLAICH et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: